Skip to Content

UK Edition. Click here for US version.


Active substance(s): LORATADINE

View full screen / Print PDF » Download PDF ⇩
Package leaflet:
Information for the user

Selariz10 mg
Read all of this leaflet carefully before you
start taking this medicine because it
contains important information for you
Always take this medicine exactly as described in
this leaflet or as your doctor, pharmacist, or nurse
has told you
- Keep this leaflet. You may need to read it again.
- Ask your pharmacist if you need more
information or advice.
- If you get any side effects, talk to your doctor,
pharmacist, or nurse. This includes any
possible side effects not listed in this leaflet.
See section 4.
- You must talk to a doctor if you do not feel
better, if you feel worse.

Warnings and precautions
Talk to your doctor, pharmacist or nurse before
taking Selariz Tablets

if you have severe liver problems


if you are scheduled to have any skin tests for
allergies. Do not take Selariz tablets for two
days before having these tests. This is
because it may affect test results.

If any of the above applies to you, please tell your
doctor or pharmacist.
Other medicines and Selariz Tablets
Tell your doctor or pharmacist if you are taking,
have recently taken or might take any other
medicines. This includes taken without a prescription.
This is particularly important if you are taking
- Cimetidine (for stomach problems)
- Erythromycin (an antibiotic)
- Ketoconazole or fluconazole (for fungal

What is in this leaflet:
1. What Selariz Tablets are and what
they are used for
2. What you need to know before you take
Selariz Tablets
3. How to take Selariz Tablets
4. Possible side effects
5. How to store Selariz Tablets
6. Contents of the pack and other information
1. What selariz tablets are and what they are
used for
This medicine contains the active substance
loratadine which belongs to a class of medicines
called "antihistamines".
Selariz Tablets relieve symptoms associated with
allergic rhinitis (for example, hay fever),
such as sneezing, runny or itchy nose, and burning
or itchy eyes.
Selariz tablets may also be used to help relieve
symptoms of urticaria (itching, redness and
number and size of hives).

Selariz Tablets with alcohol
Selariz Tablets has not been shown to add to the
effects of an alcoholic drink.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you
may be pregnant or are planning to have a baby,
ask your doctor or pharmacist for advice before
taking this medicine.
Pregnancy: Do not take Selariz Tablets if you are
Breast feeding: Do not take Selariz Tablets if you
are breast-feeding. Loratadine is excreted in breast
Driving and using machines
At the recommended dose, Selariz Tablets are not
expected to cause you to be drowsy or less alert.
However, very rarely some patients
experience drowsiness, which may affect their
ability to drive or use machines. Please make sure
you are not drowsy before performing these
Selariz Tablets contains lactose

Relief of these symptoms lasts a full day and helps
you to resume your normal daily activities and sleep.
You must talk to a doctor if you do not feel better or
if you feel worse.

Selariz Tablets contain lactose; thus if you have
been told by your doctor that you have an
intolerance to some sugars, contact your doctor
before taking this medicine.
3. How to take selariz tablets

2. What you need to know before you take
Selariz Tablets
DO NOT TAKE Selariz Tablets

if you are allergic (hypersensitive) to
loratidine or any of the other ingredients of
this medicine (listed in section 6)


if you are pregnant or planning to become


if you are breast-feeding currently.

Children under 2 years of age and/or under 30 kg
of weight should not take this medicine.

Always take this medicine exactly as as your
doctor or pharmacist has told you. Check with
your doctor or pharmacist if you are not sure.
Try to get into the habit of taking it at the same
time every day. This will make it easier for you to
The Central breakline of the tablet is only there to
help you the break the tablet if you have difficulty
swallowing it whole.
Giving this medicine to children:
A loratadine syrup formulation may be preferable
for children. It is important to know how much
your child weights to make sure that you give the

correct amount of the medicine. For example, a 9
year old child weight about 30 kg (4st 7lbs). if in
doubt weigh your child and then follow the
instructions in the table.
The usual dose is

skin rashes
hair loss
dry mouth
serious allergic reaction which causes swelling
of the face or throat

Reporting of side effects
If you get any side effects, talk to your doctor,
pharmacist or nurse. This includes any possible
side effects not listed in this leaflet. You can also
report side effects directly via the Yellow Card
Scheme at:
By reporting side effects you can help provide
more information on the safety of this medicine

Adults and children
over 12 years of age

10 mg once daily
(swallow one tablet
daily with water)

Children aged 2 to 12
years and weighing
over 30 kg

10 mg once daily
(swallow one tablet
daily with water)

Children who are aged
over 2 years old but do
not weigh more than
30 kg

Should not take this

Children under 2 years
of age

Should not take this


Patients with severe
liver problems

Your doctor may
prescribe a different
dose for patients with
severe liver problems


5. How to store selariz tablets

If you take more Selariz Tablets than you
If you may have taken more Loratadine than you
should, talk to your doctor or pharmacist
immediately. Overdose may cause sleepiness or a
faster heart beat. Immediate medical attention
should be sought in the event of an overdose;
take your tablets along to show to your doctor, if
If you forget to take Selariz Tablets
If you have forgotten to take your tablet, take it as
soon as you remember and continue as usual. Do
not take a double dose to make up for a forgotten
If you have any further questions on the use of this
product, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side
effects, although not everybody gets them.
The most commonly reported side effects in
adults and children over 12 years of age are:
- drowsiness
- headache
- increased appetite
- difficulty sleeping
The most commonly reported side effects in
children aged 2 through 12 years are:
- headache
- nervousness
- tiredness
The following very rare side effects (may affect
up to 1 in 10,000 people) have also been seen
during the marketing of loratadine:
- severe allergic reaction which cause difficulty
in breathing or dizziness.
- rapid heartbeat
- palpitation (awareness of heartbeat/racing)
- gastritis (abdominal pain, burning feeling in
the stomach between meals or at night and
nausea (with or without vomiting)
- feeling tired

Keep out of the sight and reach of children.
Do not take Selariz Tablets after the expiry
date which is stated on the carton after “Exp”.
The expiry date refers to the last day of that
Store in the original package.
Do not throw away any medicines via
wastewater or household waste. Ask your
pharmacist how to throw away medicines you
no longer use. These measures will help to
protect the environment.
6. Contents of the pack and other information

What Selariz Tablets contain
- The active substance is loratadine.
- The other ingredients are lactose monohydrate,
maize starch, colloidal anhydrous silica,
croscarmellose sodium, talc and
magnesium stearate.
What Selariz Tablets look like and contents of
the pack
Selariz Tablets are white coloured, circular, flat
beveled uncoated tablets, with central breakline on
one side and ‘L’ on other side.
Selariz Tablets are available in blister strips in
pack size of 7, 10,14, 20 and 30 tablets.
Not all pack sizes may be marketed.
Marketing Authorisation Holder
Cipla (EU) Limited, Hillbrow House, Hillbrow
Road, Esher, Surrey, KT10 9NW, United Kingdom.
Cipla (EU) Limited,
20 Balderton Street, London W1K 6TL,
United Kingdom
Cipla Europe NV
Uitbreidingstraat 80, 2600 Antwerp, Belgium
This leaflet was last revised in 08/2016.




Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.